Nifurtimox response of Trypanosoma cruzi isolates from an outbreak of Chagas disease in Caracas, Venezuela
Background & objectives: In Venezuela, Chagas disease (ChD) is considered a serious health problem, with about 6 million people at risk; and acute outbreaks due to oral transmission of Chagas Disease (OChD) are becoming increasingly important. In 2007 there was a major outbreak of OChD and altho...
Main Authors: | Arturo Munoz-Calderon, Zoraida Díaz-Bello, José Luis Ramírez, Oscar Noya, Belkisyolé Alarcón de Noya |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
Series: | Journal of Vector Borne Diseases |
Subjects: | |
Online Access: | http://www.jvbd.org/article.asp?issn=0972-9062;year=2019;volume=56;issue=3;spage=237;epage=243;aulast=Munoz-Calderon |
Similar Items
-
Sensibilidad in vitro a benznidazol, nifurtimox y posaconazol de cepas de Trypanosoma cruzi de Paraguay
by: Nidia Acosta, et al.
Published: (2020-12-01) -
Nifurtimox versus benznidazole or placebo for asymptomatic Trypanosoma cruzi infection (Equivalence of Usual Interventions for Trypanosomiasis - EQUITY): study protocol for a randomised controlled trial
by: Juan Carlos Villar, et al.
Published: (2019-07-01) -
Susceptibilidad in vitro a hexadecilfosfocolina (miltefosina), nifurtimox y benznidazole de cepas de Trypanosoma cruzi aisladas en Santander, Colombia
by: Patricia Escobar, et al.
Published: (2009-09-01) -
Dipyridamole potentiated the trypanocidal effect of nifurtimox and improved the cardiac function in NMRI mice with acute chagasic myocarditis
by: Sonia Santeliz, et al. -
Terapêutica da fase crônica da infecção experimental pelo Trypanosoma cruzi com o Benzonidazol e o Nifurtimox
by: Sonia G. Andrade, et al.
Published: (1989-09-01)